The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaya, Z.
Right arrow Articles by Rose, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaya, Z.
Right arrow Articles by Rose, N. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
*Cardiomyopathy
The Journal of Immunology, 2002, 168: 1552-1556.
Copyright © 2002 by The American Association of Immunologists

Cutting Edge

Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis1

Ziya Kaya*, K. Malte Dohmen*, Yan Wang*,{dagger}, Jens Schlichting*, Marina Afanasyeva*,{dagger}, Florian Leuschner* and Noel R. Rose2,*,{dagger}

Departments of * Pathology and {dagger} Molecular Microbiology and Immunology, Johns Hopkins Medical Institutions, Baltimore, MD 21205

Appropriate treatment of autoimmune myocarditis following virus infection remains a major clinical problem. Induction of nasal tolerance may provide a new approach to treatment. However, the exact mechanism of nasal tolerance is unknown. To assess the mechanism of nasal tolerance, we examined the role of IL-10 in the induction and suppression of autoimmune myocarditis. First we showed that blocking IL-10 concurrent with nasal administration of Ag abolished the disease-suppressing effect of nasal tolerization. It also led to increased cardiac myosin-specific IL-1 and TNF-{alpha} production. Then we demonstrated that blocking IL-10 during the effector phase increased not only the incidence and severity of disease but also Ag-specific IL-2, IL-4, and TNF-{alpha} production as well as cardiac myosin-specific IgG1 and IgG2b production, whereas blocking IL-10 during the induction phase had no effect. This study implicates IL-10 in the induction of nasal tolerance and in limiting inflammation later during the disease process.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. B. Silver, R. K. Agarwal, S.-B. Su, I. Suffia, R. S. Grajewski, D. Luger, C.-C. Chan, R. M. Mahdi, J. M. Nickerson, and R. R. Caspi
Hydrodynamic Vaccination with DNA Encoding an Immunologically Privileged Retinal Antigen Protects from Autoimmunity through Induction of Regulatory T Cells
J. Immunol., October 15, 2007; 179(8): 5146 - 5158.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Szalay, M. Sauter, J. Hald, A. Weinzierl, R. Kandolf, and K. Klingel
Sustained Nitric Oxide Synthesis Contributes to Immunopathology in Ongoing Myocarditis Attributable to Interleukin-10 Disorders
Am. J. Pathol., December 1, 2006; 169(6): 2085 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Goser, M. Andrassy, S. J. Buss, F. Leuschner, C. H. Volz, R. Ottl;, S. Zittrich;, N. Blaudeck, S. E. Hardt, G. Pfitzer, et al.
Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium
Circulation, October 17, 2006; 114(16): 1693 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. R. Marty, S. Dirnhofer, N. Mauermann, S. Schweikert, S. Akira, L. Hunziker, J. M. Penninger, and U. Eriksson
MyD88 Signaling Controls Autoimmune Myocarditis Induction
Circulation, January 17, 2006; 113(2): 258 - 265.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Goser, R. Ottl;, A. Brodner, T. J. Dengler, J. Torzewski, K. Egashira, N. R. Rose, H. A. Katus, and Z. Kaya
Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1{alpha} in Induction of Experimental Autoimmune Myocarditis and Effective Anti-Monocyte Chemoattractant Protein-1 Gene Therapy
Circulation, November 29, 2005; 112(22): 3400 - 3407.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Li, J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham
Protection against Experimental Autoimmune Myocarditis Is Mediated by Interleukin-10-Producing T Cells that Are Controlled by Dendritic Cells
Am. J. Pathol., July 1, 2005; 167(1): 5 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Taylor, K. McConnachie, C. Calder, R. Dawson, A. Dick, J. D. Sedgwick, and J. Liversidge
Enhanced Tolerance to Autoimmune Uveitis in CD200-Deficient Mice Correlates with a Pronounced Th2 Switch in Response to Antigen Challenge
J. Immunol., January 1, 2005; 174(1): 143 - 154.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Z. Zhu, D. Stevenson, J. E. Schechter, A. K. Mircheff, T. Ritter, L. Labree, and M. D. Trousdale
Prophylactic Effect of IL-10 Gene Transfer on Induced Autoimmune Dacryoadenitis
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1375 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
M. Afanasyeva and N.R. Rose
Immune mediators in inflammatory heart disease: insights from a mouse model
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I31 - I36.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.